Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
APPIRED-III: RESCAP in Cardiac Surgery
NCT03050476Phase 3Recruiting
- Sponsor
- Alloksys Life Sciences
- Start
- Nov 2017
- Primary completion
- Sep 2025
- Modality
- Replacement Enzymes
- Countries
- 11
01
Overview
A Phase 3 trial of bovine intestinal alkaline phosphatase in acute kidney injury (AKI), Systemic Inflammatory Response Syndrome (SIRS), sponsored by Alloksys Life Sciences. Started Nov 2017; status: recruiting.
02
Drugs
bovine intestinal alkaline phosphatase
03
Conditions
acute kidney injury (AKI)Systemic Inflammatory Response Syndrome (SIRS)
Beyond the preview
Go deeper on NCT03050476.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03050476.